Author

Christine A. Parachoniak

Observed names: C.A. Parachoniak, Christine A Parachoniak, Christine Anna Parachoniak, Christine Parachoniak, Christine A. Parachoniak, Christine Anna Parachoniak, Parachoniak, Christine

Institution: Foundation Medicine (United States)

Observed institutions: BC Cancer Agency, Harvard University, University of British Columbia, Massachusetts General Hospital, Merck Canada Inc. (Canada), Foundation Medicine (United States), Institut du cancer Rosalind & Morris Goodman, McGill University

ORCID: 0009-0002-3516-2686

Observed ORCID: 0009-0002-3516-2686

OpenAlex ID: A5005813857

VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

2012 · Kan V. Lu, Jeffrey P. Chang, et al. · Cancer Cell · 579

PDF

Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

2014 · Supriya K. Saha, Christine A. Parachoniak, et al. · Nature · 481

YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression

2015 · Julien Fitamant, Filippos Kottakis, et al. · Cell Reports · 258

PDF

GGA3 Functions as a Switch to Promote Met Receptor Recycling, Essential for Sustained ERK and Cell Migration

2011 · Christine Anna Parachoniak, Yi Luo, et al. · Developmental Cell · 150

PDF

Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples

2022 · Hatim Husain, Dean C. Pavlick, et al. · JCO Precision Oncology · 117

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer

2018 · R.J. Hartmaier, S.E. Trabucco, et al. · Annals of Oncology · 111

PDF

Structure-Function Relationships in the Neuropeptide S Receptor

2006 · Virginie Bernier, Rino Stocco, et al. · Journal of Biological Chemistry · 94

Dynamics of receptor trafficking in tumorigenicity

2012 · Christine A. Parachoniak, Morag Park · Trends in Cell Biology · 61

Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types

2023 · Pashtoon M. Kasi, Jessica K. Lee, et al. · Clinical Cancer Research · 59

PDF

Expression of rearranged TCRγ genes in natural killer cells suggests a minor thymus-dependent pathway of lineage commitment

2005 · Linnea Lora Veinotte, Chelsea Pamela Greenwood, et al. · Blood · 59

PDF

Regulation of Cell Migration and β1 Integrin Trafficking by the Endosomal Adaptor GGA3

2016 · Colin D. H. Ratcliffe, Pranshu Sahgal, et al. · Traffic · 51

IDH mutations in liver cell plasticity and biliary cancer

2014 · Supriya K Saha, Christine A Parachoniak, et al. · Cell Cycle · 46

PDF

Dorsal Ruffle Microdomains Potentiate Met Receptor Tyrosine Kinase Signaling and Down-regulation

2010 · Jasmine V. Abella, Christine A. Parachoniak, et al. · Journal of Biological Chemistry · 46

Distinct Recruitment of Eps15 via Its Coiled-coil Domain Is Required For Efficient Down-regulation of the Met Receptor Tyrosine Kinase

2008 · Christine A. Parachoniak, Morag Park · Journal of Biological Chemistry · 37

PDF

Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant

2017 · Christine A. Parachoniak, Andrew Rankin, et al. · Molecular Case Studies · 25

PDF

Prevalence of inferred clonal hematopoiesis (CH) detected on comprehensive genomic profiling (CGP) of solid tumor tissue or circulating tumor DNA (ctDNA).

2021 · Emmanuel S. Antonarakis, Zheng Kuang, et al. · Journal of Clinical Oncology · 15

Erratum: Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer

2015 · Supriya K. Saha, Christine A. Parachoniak, et al. · Nature · 14

PDF

CLIP‐170 spatially modulates receptor tyrosine kinase recycling to coordinate cell migration

2018 · Kossay Zaoui, Stephanie Duhamel, et al. · Traffic · 12

MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel MET R1004G Mutation

2019 · Lisa Pei Chu, Debra Franck, et al. · The Oncologist · 9

PDF

Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1+ T cells

2007 · Erica B. Wilson, Christine A. Parachoniak, et al. · Immunogenetics · 6

Supplementary Data 1 from Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types